Physician profile
Leslie E Easley
NPI 1265639637
$2,194.30
in general payments reported to CMS, 2019-2025
18 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $277 · 2021: $298 · 2022: $537 · 2023: $408 · 2024: $25.03 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $352.56 | 2020-2024 | Xarelto |
| Boston Scientific Corporation | $289.56 | 2020-2025 | General - Vascular Intervention, General - Therapies, General - Pain Management |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.55 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.62 | 2022-2025 | Jardiance |
| Inari Medical, INC. | $150.54 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $147.66 | 2022 | |
| Amgen INC. | $142.50 | 2020-2023 | Repatha |
| Edwards Lifesciences Corporation | $130.94 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Intuitive Surgical, INC. | $127.47 | 2025 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Vifor Pharma, INC. | $124.84 | 2019 | |
| Abbott Laboratories | $63.50 | 2023 | Confirm Rx |
| Esperion Therapeutics, INC. | $35.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.55 | 2021 | |
| Allergan, INC. | $16.50 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Easley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.